Pillstats
Rx only · Powder, For Suspension · Oral

Sodium Polystyrene Sulfonate

Sodium Polystyrene Sulfonate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)56512
US makers7 labelers
Packages18
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.074$0.147$0.221$0.295Dec 2025Apr 2026Jul 2026
$0.256
Latest avg · Jul 22, 2026
+11%
Since Dec 17, 2025
7
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7611.5K2.3K3.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.3K
Rx · 2026 Q1
664K
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager6SUPPLYING
SUNRISE PHARMACEUTICAL, INCunknown3SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING
ATLANTIC BIOLOGICALS CORP.unknown2SUPPLYING
Epic Pharma, LLCunknown2SUPPLYING
PURACAP LABORATORIES, LLCunknown1SUPPLYING
CMP Pharma, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.